Skip to main content

Advertisement

SpringerLink
Log in

Pancreatic Involvement by Plasma Cell Neoplasms

  • REVIEW
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

Pancreatic involvement by plasma cell neoplasms is an extremely rare event, with only 50 cases described in the literature. They can present as a primary solitary extramedullary plasmacytoma or plasmacytoma secondary to a plasma cell myeloma. Clinical manifestations are due to the presence of a pancreatic mass usually in the pancreas head, which causes extra-biliary obstruction and abdominal pain.

Methods

Abdominal imaging including CT scan or endoscopic ultrasound with fine-needle aspiration tissue sampling is essential for the initial diagnostic procedure. However, immunohistochemical analysis of the biopsy specimen or flow cytometry of the aspirated material is crucial to prove the monoclonality and the final diagnosis of a plasma cell neoplasm.

Discussion

Management of these situations include radiotherapy, chemotherapy, surgery or combined therapy. Novel medications including the immunomodulatory drugs or the proteasome inhibitors followed by consolidation with intensive chemotherapy and haematopoietic stem cell transplantation are nowadays used as upfront treatment in the cases associated to a plasma cell myeloma.

Conclusion

Despite the rarity, plasma cell neoplasms should be considered in the differential diagnosis of obstructive jaundice and pancreatic neoplasms since they are potentially treatable situations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Saif MW. Primary pancreatic lymphomas. JOP. 2006;7:262–73.

    PubMed  Google Scholar 

  2. Swerdlow SH, Campo E, Harry NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues; 2008.

  3. Tomita T. Amyloidosis of pancreatic islets in primary amyloidosis (AL type). Pathol Int. 2005;55:223–7.

    Article  PubMed  Google Scholar 

  4. Höppener JW, Nieuwenhuis MG, Vroom TM, Lips CJ. Islet amyloid and diabetes mellitus type 2. Ned Tijdschr Geneeskd. 2000;144:1995–2000.

    PubMed  Google Scholar 

  5. Gandhi GY, Basu R, Dispenzieri A, Basu A, Montori VM, Brennan MD. Endocrinopathy in POEMS syndrome: the Mayo Clinic experience. Mayo Clin Proc. 2007;82:836–42.

    Article  PubMed  Google Scholar 

  6. Alexiou C, Kau RJ, Dietzfelbinger H, et al. Extramedullary plasmacytoma: tumour occurence and therapeutic concepts. Cancer. 1999;85:2305–14.

    Article  PubMed  CAS  Google Scholar 

  7. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.

    Article  PubMed  Google Scholar 

  8. Ries LA, et al., editors. SEER Cancer Statistics Review, 1975–2001. National Cancer Institute, Bethesda, MD; 2004.

  9. Anon. Criteria for the classification of monoclonal gammophaties, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749–57.

    Article  Google Scholar 

  10. Hefferman A. Plasmacytoma of pancreas and duodenum causing acute intestinal obstruction. Lancet. 1947;1:910.

    Article  PubMed  CAS  Google Scholar 

  11. Richards WG, Katzmann FS, Coleman FC. Extramedullary plasmacytoma arising in the head of the pancreas: report of a case. Cancer. 1958;11:649–52.

    Article  PubMed  CAS  Google Scholar 

  12. Doutre LP, Leger H, Bobois JP, Diard F. Extra skeletal plasmacytic sarcoma located in the pancreas. Chirurgie. 1976;102:130–5.

    PubMed  CAS  Google Scholar 

  13. Simon TL, Rughani IK, Pierson DJ, Hebard DW. Multiple plasmacytomas with thoracic and biliary involvement. Arch Intern Med. 1978;138:1165–7.

    Article  PubMed  CAS  Google Scholar 

  14. Rice NT, Woodring JH, Mostowycz L, Purcell M. Pancreatic plasmacytoma: sonographic and computerized tomographic findings. J Clin Ultrasound. 1981;9:46–8.

    Article  PubMed  CAS  Google Scholar 

  15. Bell HG, David R, Shamsuddin AM. Extrahepatic biliary obstruction and liver failure secondary to myeloma of the pancreas. Hum Pathol. 1982;13:940–2.

    Article  PubMed  CAS  Google Scholar 

  16. Twomey BP, Katz D. Computed tomography in the diagnosis of extramedullary plasmacytoma. J Comput Tomogr. 1983;7:407–8.

    Article  PubMed  CAS  Google Scholar 

  17. Borgia G, Ciampi R, Nappa S, Vallone G, Iovinella V, Crowell J. Clinical and diagnostic considerations on a case of pancreatic plasmacytoma. Minerva Med. 1984;75:2839–42.

    PubMed  CAS  Google Scholar 

  18. Borgia G, Ciampi R, Nappa S, Iovinella V, Crowell J. Pancreatic plasmacytoma: an unusual cause of obstructive jaundice. Arch Pathol Lab Med. 1984;108:773–4.

    PubMed  CAS  Google Scholar 

  19. Helenon O, Bonnel D, Bigot JM, Carette MF, Pene F. Plasmacytoma of the head of the pancreas. Diagnosis by puncture aspiration guided by echography. Presse Med. 1984;13:2645.

    PubMed  CAS  Google Scholar 

  20. Görg C, Schwerk W, Görg K, Pflüger KH, Havemann K. Extrahepatic biliary obstruction caused by infiltration of the pancreas by plasmacytoma. Klin Wochenschr. 1985;63:718–21.

    Article  PubMed  Google Scholar 

  21. Jaubert D, Hauteville D, Verdier M, et al. Plasmacytoma of the head of the pancreas: a rare cause of cholestatic jaundice. Gastroenterol Clin Biol. 1985;9:532–4.

    PubMed  CAS  Google Scholar 

  22. Mitchell DG, Hill MC. Obstructive jaundice due to multiple myeloma of the pancreatic head: CT evaluation. J Comput Assist Tomogr. 1985;9:1118–9.

    PubMed  CAS  Google Scholar 

  23. Speelberg B, Kluin PM, Punt K, Lips CJ. Non-secreting extramedullary plasmacytoma with late involvement of the pancreas causing obstructive jaundice. Neth J Med. 1985;28:291–94.

    PubMed  CAS  Google Scholar 

  24. Zafaranloo S, Bryk D, Gerard PS. Obstructive jaundice secondary to multiple myeloma—a case report. Comput Radiol. 1986;10:197–200.

    Article  PubMed  CAS  Google Scholar 

  25. Scheiman J, Elta G, Francis I. Biliary obstruction secondary to an extramedullary plasmacytoma of the pancreas: confusion with pancreatitis on computed tomography. Pancreas. 1987;2:237–9.

    Article  PubMed  CAS  Google Scholar 

  26. Akiyama H, Krigel RL. Metastatic extramedullary plasmacytoma: a case report and review of the literature of a rare pseudocarcinoma. Am J Hematol. 1988;27:115–7.

    Article  PubMed  CAS  Google Scholar 

  27. Fukuya T, Yoshimitsu K, Kitagawa S, Murakami J, Masuda K, Nakamura K. Plasmacytoma of the pancreatic head. Gastrointest Radiol. 1989;14:226–8.

    Article  PubMed  CAS  Google Scholar 

  28. Wilson TE, Korobkin M, Francis IR. Pancreatic plasmacytoma: CT findings. AJR Am J Roentgenol. 1989;152:1227–8.

    PubMed  CAS  Google Scholar 

  29. Brichon P, Solary E, Caillot D, Boussuge C, et al. Extramedullary pancreatic localization of myeloma. Ann Med Interne (Paris). 1989;140:421–2.

    CAS  Google Scholar 

  30. Hamamoto K, Kosaka C, Takeno M, et al. Multiple myeloma causing obstructive jaundice by extramedullary plasmacytoma after Bence Jones protein loss—an autopsy case report. Rinsho Ketsueki. 1990;31:57–61.

    PubMed  CAS  Google Scholar 

  31. Fischer A, Suhrland MJ, Vogl SE. Myeloma of the head of the pancreas. A case report Cancer. 1991;67:681–3.

    CAS  Google Scholar 

  32. Davidson BS, Lee JE, Dodd LG, Dimopoulos MA, Evans DB. Extramedullary plasmacytoma of the pancreas. Am J Clin Oncol. 1993;16:363–8.

    Article  PubMed  CAS  Google Scholar 

  33. Olson MC, Kalbhen CL, Posniak HV. Pancreatic plasmacytomas in a patient with multiple myeloma: CT and ultrasound findings. Abdom Imaging. 1993;18:323–4.

    Article  PubMed  CAS  Google Scholar 

  34. Fautrel B, Marolleau JP, Charleux F, Brice P, Frija J, Gisselbrecht C. Pancreatic and hepatic plasmocytomas: an exceptional case. Nouv Rev Fr Hematol. 1993;35:125–8.

    PubMed  CAS  Google Scholar 

  35. Tanaka Y, Samma S, Hayashi Y, et al. A case of retroperitoneal extramedullary plasmacytoma. Hinyokika Kiyo. 1993;39:639–43.

    PubMed  CAS  Google Scholar 

  36. Ohno T, Saka Y, Horii J, et al. Aggressive transformation of an indolent myeloma with abdominal extramedullary plasmacytoma after 6-year period of observation. Rinsho Ketsueki. 1994;35:390–6.

    PubMed  CAS  Google Scholar 

  37. Dodd LG, Evans DB, Symmans F, Katz RL. Fine-needle aspiration of pancreatic extramedullary plasmacytoma: possible confusion with islet cell tumor. Diagn Cytopathol. 1994;10:371–4.

    Article  PubMed  CAS  Google Scholar 

  38. Abu-Hammour AM, Venu RP, Etzkorn KP, Showel JL, Zaytsev PM, Brown RD. Common bile duct obstruction caused by multiple myeloma of the pancreas. Gastrointest Endosc. 1996;44:606–8.

    Article  PubMed  CAS  Google Scholar 

  39. Pääkkö E, Autio R, Lähde S. Plasmacytoma of the pancreas: CT and MRI appearance. Rofo. 1998;169:673–5.

    Article  PubMed  Google Scholar 

  40. Ríos A, Ramírez P, Majado MA, Parrilla P. Obstructive jaundice caused by pancreatic head tumor secondary to IgG multiple myeloma. Rev Esp Enferm Dig. 2000;92:475–6.

    PubMed  Google Scholar 

  41. Hirata S, Yamaguchi K, Bandai S, Izumo A, Chijiiwa K, Tanaka M. Secondary extramedullary plasmacytoma involving the pancreas. J Hepatobiliary Pancreat Surg. 2002;9:111–5.

    Article  PubMed  Google Scholar 

  42. Balliu E, Casas JD, Barluenga E, Guasch I. Multifocal involvement of the pancreas in multiple myeloma: sonographic, CT, and MR imaging findings. AJR Am J Roentgenol. 2003;180:545–6.

    PubMed  Google Scholar 

  43. Hiller N, Goitein O, Ashkenazi YJ. Plasmacytoma of the pancreas. Isr Med Assoc J. 2004;6:704–5.

    PubMed  Google Scholar 

  44. Coban S, Koklu S, Ertugrul I, Kuzu I, Bahar K. Obstructive jaundice in a patient with multiple myeloma. J Gastroenterol Hepatol. 2004;19:837–8.

    Article  PubMed  Google Scholar 

  45. Deguchi Y, Nonaka A, Takeuchi E, Funaki N, Kono Y, Mizuta K. Primary pancreatic plasmacytoma. Am J Clin Oncol. 2004;27:247–9.

    Article  PubMed  Google Scholar 

  46. Kazama T, Ng CS, Giralt SA. Multiphasic CT and MRI appearances of extramedullary multiple myeloma involving the stomach, pancreas, and bladder. Clin Imaging. 2005;29:263–5.

    Article  PubMed  Google Scholar 

  47. Ali R, Ozkalemkas F, Ozcelik T, et al. Extramedullary plasmacytoma involving the abdominal vessels and pancreas. Dig Dis Sci. 2007;52:3199–201.

    Article  PubMed  Google Scholar 

  48. Hameed A, Ryan M, Kamel D, Vusirikala M. Plasmacytoma of the pancreas and pelvis: a case report. Lab Hematol. 2008;14:10–1.

    Google Scholar 

  49. Atiq M, Ali SA, Dang S, et al. Pancreatic plasmacytoma presenting as variceal hemorrhage: life threatening complication of a rare entity. JOP. 2009;10:187–8.

    PubMed  Google Scholar 

  50. Spiegel A, Patel R, Pais S. Obstructive jaundice secondary to a pancreatic plasmacytoma. Clin Gastroenterol Hepatol. 2009;7:A32.

    Article  PubMed  Google Scholar 

  51. Gupta P, Rice GD, Abraham K, Ghole V, Ketkar M. Extramedullary plasmacytoma of the pancreas and jejunum. Clin Imaging. 2009;33:240–3.

    Article  PubMed  Google Scholar 

  52. Leake PA, Coard KC, Plummer JM. Extramedullary plasmacytoma of the pancreas as an uncommon cause of obstructive jaundice: a case report. J Med Case Reports. 2009;3:8785.

    Article  PubMed  Google Scholar 

  53. Wei JY, Tong HY, Zhu WF, et al. Bortezomib in treatment of extramedullary plasmacytoma of the pancreas. Hepatobiliary Pancreat Dis Int. 2009;8:329–31.

    PubMed  Google Scholar 

  54. Annibali O, Marchesi F, Petrucci MT, Tirindelli MC, Avvisati G. Relapse of IgA lambda multiple myeloma presenting as obstructive jaundice and abdominal pain. Onkologie. 2009;32:119–21.

    Article  PubMed  Google Scholar 

  55. Padda MS, Milless T, Adeniran AJ, Mahooti S, Aslanian HR. Pancreatic and gastric plasmacytoma presenting with obstructive jaundice, diagnosed with endoscopic ultrasound-guided fine needle aspiration. Case Rep Gastroenterol. 2010;4:410–5.

    Article  PubMed  Google Scholar 

  56. Coss A, Zhou C, Byrne MF, Weiss AA. Relapse of multiple myeloma presenting with biliary obstruction. Can J Gastroenterol. 2010;24:237–8.

    PubMed  Google Scholar 

  57. Artifon E, Okawa L, Baba E, Moura E, Sakai P, Savides T. Diagnosis of pancreatic plasmacytoma by endoscopic ultrasound-fine needle aspiration. Rev Gastroenterol Mex. 2010;75:357–9.

    Google Scholar 

  58. Pinto-Marques P, Martins C, Mendonça E, Castro H, Serra D. Pancreatic head mass of unusual etiology: multiple myeloma diagnosed by endoscopic ultrasound-guided fine needle aspiration. Endoscopy. 2010;42 Suppl 2:E263–4.

    Article  PubMed  Google Scholar 

  59. Gritzmann N, Macheiner P, Hollerweger A, Hübner E. CT in the differentiation of pancreatic neoplasms—progress report. Dig Dis. 2004;22:6–17.

    Article  PubMed  Google Scholar 

  60. Kauhanen SP, Komar G, Seppänen MP, et al. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Ann Surg. 2009;250:957–63.

    Article  PubMed  Google Scholar 

  61. Farma JM, Santillan AA, Melis M, et al. PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann Surg Oncol. 2008;15:2465–71.

    Article  PubMed  Google Scholar 

  62. Itani KM, Taylor TV, Green LK. Needle biopsy for suspicious lesions of the head of the pancreas: pitfalls and implications for therapy. J Gastrointest Surg. 1997;1:337–41.

    Article  PubMed  CAS  Google Scholar 

  63. Turner BG, Cizginer S, Agarwal D, Yang J, Pitman MB, Brugge WR. Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy. Gastrointest Endosc. 2010;71:91–8.

    Article  PubMed  Google Scholar 

  64. Sheridan MB, Ward J, Guthrie JA, et al. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis. AJR Am J Roentgenol. 1999;173:583–90.

    PubMed  CAS  Google Scholar 

  65. Adamek HE, Albert J, Breer H, Weitz M, Schilling D, Riemann JF. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet. 2000;356:190–3.

    Article  PubMed  CAS  Google Scholar 

  66. Yamaguchi K, Chijiwa K, Shimizu S, Yokohata K, Morisaki T, Tanaka M. Comparison of endoscopic retrograde and magnetic resonance cholangiopancreatography in the surgical diagnosis of pancreatic diseases. Am J Surg. 1998;175:203–8.

    Article  PubMed  CAS  Google Scholar 

  67. Islam S, Callery MP. Primary pancreatic lymphoma—a diagnosis to remember. Surgery. 2001;129:380–3.

    Article  PubMed  CAS  Google Scholar 

  68. Salvatore JR, Cooper B, Shah I, Kummet T. Primary pancreatic lymphoma: a case report, literature review, and proposal for nomenclature. Med Oncol. 2000;17:237–47.

    Article  PubMed  CAS  Google Scholar 

  69. van Gulik TM, Moojen TM, van Geenen R, Rauws EA, Obertop H, Gouma DJ. Differential diagnosis of focal pancreatitis and pancreatic cancer. Ann Oncol. 1999;10 Suppl 4:85–8.

    Article  PubMed  Google Scholar 

  70. Mayr NA, Wen BC, Hussey DH, et al. The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol. 1990;17:293–303.

    Article  PubMed  CAS  Google Scholar 

  71. Jyothirmayi R, Gangadharan VP, Nair MK, Rajan B. Radiotherapy in the treatment of solitary plasmacytoma. Br J Radiol. 1997;70:511–6.

    PubMed  CAS  Google Scholar 

  72. Kumar S, Rajkumar SV. Thalidomide and dexamethasone: therapy for multiple myeloma. Expert Rev Anticancer Ther. 2005;5:759–66.

    Article  PubMed  CAS  Google Scholar 

  73. Rajkumar SV, Hayman S, Gertz MA, et al. Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma. J Clin Oncol. 2002;20:4319.

    Article  PubMed  CAS  Google Scholar 

  74. Wang M, Weber D, Delasalle K, et al. Thalidomide–dexamethasone as primary therapy for advanced multiple myeloma. Am J Hematol. 2005;79:194.

    Article  PubMed  CAS  Google Scholar 

  75. Cavo M, Zamagni E, Tosi P, et al. Superiority of thalidomide and dexamethasone over vincristine–doxorubicin–dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. Blood. 2005;106:35.

    Article  PubMed  CAS  Google Scholar 

  76. Paubelle E, Coppo P, Garderet L, et al. Complete remission with bortezomib on plasmocytomas in an end-stage patient with refractorymultiple myeloma who failed all other therapies includinghematopoietic stem cell transplantation: possibleenhancement of graft-vs-tumor effect. Leukemia. 2005;19:1702–4.

    Article  PubMed  CAS  Google Scholar 

  77. Krauth MT, Bankier A, Valent P, Kalhs P, Drach J. Sustained remission including marked regression of a paravertebral plasmacytoma in a patient with heavilypretreated, relapsed multiple myeloma after treatment with bortezomib. Leuk Res. 2005;29:1473–7.

    Article  PubMed  CAS  Google Scholar 

  78. Laura R, Cibeira MT, Uriburu C, et al. Bortezomib: an effective agent in extramedullary disease in multiple myeloma. Eur JHaematol. 2006;76:405–8.

    Article  Google Scholar 

  79. Attal M, Harousseau JL, Stoppa AM, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med. 1996;335:91.

    Article  PubMed  CAS  Google Scholar 

  80. Fermand JP, Katsahian S, Divine M, et al. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe. J Clin Oncol. 2005;23:9227.

    Article  PubMed  CAS  Google Scholar 

  81. Child JA, Morgan GJ, Davies FE, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med. 2003;348:1875.

    Article  PubMed  CAS  Google Scholar 

  82. Palumbo A, Bringhen S, Petrucci MT, et al. Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial. Blood. 2004;104:3052.

    Article  PubMed  CAS  Google Scholar 

  83. Facon T, Mary JY, Hulin C, et al. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial. Lancet. 2007;370:1209.

    Article  PubMed  CAS  Google Scholar 

  84. Hulin C, Facon T, Rodon P, et al. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial. J Clin Oncol. 2009;27:3664.

    Article  PubMed  CAS  Google Scholar 

  85. Palumbo A, Bringhen S, Caravita T, et al. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial. Lancet. 2006;367:825.

    Article  PubMed  CAS  Google Scholar 

  86. Mateos MV, Hernandez JM, Hernandez MT, et al. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study. Blood. 2006;108:2165.

    Article  PubMed  CAS  Google Scholar 

  87. Durue BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer. 1975;36:842–54.

    Article  Google Scholar 

  88. Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol. 2005;23:3412–20.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The author declares no potential conflict of interest.

Author information

Authors and Affiliations

  1. Hospital Santo António dos Capuchos–CHLC, Alameda Santo António dos Capuchos, 1169-050, Lisbon, Portugal

    Rodrigo Lopes da Silva

Authors
  1. Rodrigo Lopes da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rodrigo Lopes da Silva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lopes da Silva, R. Pancreatic Involvement by Plasma Cell Neoplasms. J Gastrointest Canc 43, 157–167 (2012). https://doi.org/10.1007/s12029-011-9314-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-011-9314-9

Keywords

Search

Navigation